The European healthcare private equity (PE) landscape is undergoing a structural reallocation of capital. Private equity sponsors, growth equity funds and institutional investors are shifting capital away from early-stage, speculative diagnostic tools and high-risk Software as a Medical Device (SaMD) platforms toward mission-critical operational workflow software.
Historically, diagnostic artificial intelligence and novel MedTech tools commanded premium valuations based on t
Nelson Advisors
Jul 23
Add a title here. Make it bold and impactful. Click to edit.
Nelson Advisors specialise in Mergers and Acquisitions for European HealthTech, MedTech, Digital Health, Healthcare IT, Healthcare AI companies in the Lower to Mid Market ranging from $25M to $250M EV.
